| Valley Oaks Health Inc | |
|
2323 Ferry St Lafayette IN 47904-3054 | |
| (765) 447-1312 | |
| Not Available |
| Full Name | Valley Oaks Health Inc |
|---|---|
| Speciality | Clinic/center - Federally Qualified Health Center (fqhc) |
| Location | 2323 Ferry St, Lafayette, Indiana |
| Authorized Official Name and Position | Thomas L. Gilliom (CEO) |
| Authorized Official Contact | 7654466540 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Valley Oaks Health Inc 415 N 26th St Lafayette IN 47904-2895 Ph: () - | Valley Oaks Health Inc 2323 Ferry St Lafayette IN 47904-3054 Ph: (765) 447-1312 |
| NPI Number | 1518710680 |
|---|---|
| Provider Enumeration Date | 04/09/2024 |
| Last Update Date | 04/09/2024 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518710680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
Newport Beach-based nonprofit Coalition Duchenne has awarded a $150,000 grant to a Cedars-Sinai Heart Institute team investigating whether an experimental cardiac stem cell treatment could be used to treat Duchenne muscular dystrophy patients who have developed heart disease.
DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that its Chattanooga division was issued U.S. Patent No. 7597656 for Chattanooga's new Moveo XP Rehabilitation Platform. The Moveo XP is the first product of its kind, allowing patients who are incapable of supporting full body weight to participate in graded weight-bearing activity at an earlier stage in their physical rehabilitation.
Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.
› Verified 7 days ago
Thomas Li Consulting Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 427 Main St Ste 210, Lafayette, IN 47901 Phone: 765-404-8099 | |
Kelly Nutrition, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5134 Florence Ln, Lafayette, IN 47905 Phone: 765-413-5609 | |
St Elizabeth Infusion Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1345 Unity Pl, Suite 365, Lafayette, IN 47905 Phone: 765-446-5417 Fax: 765-446-5317 | |
Fundamental Health, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1221 S Creasy Ln Ste K3, Lafayette, IN 47905 Phone: 765-838-2310 Fax: 765-838-1035 | |
Horizon Oncology Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1345 Unity Pl, Ste 365, Lafayette, IN 47905 Phone: 765-446-5111 Fax: 765-446-5165 | |
Valley Oaks Health Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2323 Ferry St, Lafayette, IN 47904 Phone: 866-682-5539 | |
Estep Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3774 Bayley Dr, Suite A, Lafayette, IN 47905 Phone: 765-446-5417 Fax: 765-446-5317 |